Literature DB >> 17207771

Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release.

Masanori Nakata1, Takashi Okada, Keiya Ozawa, Toshihiko Yada.   

Abstract

An adipokine resistin, a small cysteine-rich protein, is one of the major risk factors of insulin resistance. In the present study, transiently resistin-expressing mice using adenovirus method showed an impaired glucose tolerance due to insulin resistance. We found that resistin-expressing mice exhibited impaired insulin secretory response to glucose. In addition, in vitro treatment with resistin for 1 day induced insulin resistance in pancreatic islets and impaired glucose-stimulated insulin secretion by elevating insulin release at basal glucose (2.8 mM) and suppressing insulin release at stimulatory glucose (8.3 mM). In addition, resistin inhibited insulin-induced phosphorylation of Akt in islets as well as other insulin target organs. Furthermore, resistin induced SOCS-3 expression in beta-cells. In conclusion, resistin induces insulin resistance in islet beta-cells at least partly via induction of SOCS-3 expression and reduction of Akt phosphorylation and impairs glucose-induced insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17207771     DOI: 10.1016/j.bbrc.2006.12.134

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Gut Microbiota in Obesity and Undernutrition.

Authors:  Nicolien C de Clercq; Albert K Groen; Johannes A Romijn; Max Nieuwdorp
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 2.  The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis.

Authors:  James Cantley
Journal:  Mamm Genome       Date:  2014-08-22       Impact factor: 2.957

3.  Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes.

Authors:  Sahmin Lee; Hyun-Chae Lee; Yoo-Wook Kwon; Sang Eun Lee; Youngjin Cho; Joonoh Kim; Soobeom Lee; Ju-Young Kim; Jaewon Lee; Han-Mo Yang; Inhee Mook-Jung; Ky-Youb Nam; Junho Chung; Mitchell A Lazar; Hyo-Soo Kim
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

4.  Resistin is produced by rat pancreatic islets and regulates insulin and glucagon in vitro secretion.

Authors:  Maciej Sassek; Ewa Pruszynska-Oszmalek; Paweł A Kołodziejski; Dawid Szczepankiewicz; Przemyslaw Kaczmarek; Marianna Wieloch; Katarzyna Kurto; Leszek Nogowski; Krzysztof W Nowak; Mathias Z Strowski; Pawel Mackowiak
Journal:  Islets       Date:  2016-10-31       Impact factor: 2.694

5.  Intra-islet PACAP protects pancreatic β-cells against glucotoxicity and lipotoxicity.

Authors:  Masanori Nakata; Norihito Shintani; Hitoshi Hashimoto; Akemichi Baba; Toshihiko Yada
Journal:  J Mol Neurosci       Date:  2010-05-12       Impact factor: 3.444

6.  Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.

Authors:  Luiz F Rezende; Gustavo J Santos; Everardo M Carneiro; Antonio C Boschero
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

7.  Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.

Authors:  Rongjing Song; Xi Wang; Yiqing Mao; Hui Li; Zhixin Li; Wei Xu; Rong Wang; Tingting Guo; Ling Jin; Xiaojing Zhang; Yizhuang Zhang; Na Zhou; Ruobi Hu; Jianwei Jia; Zhen Lei; David M Irwin; Gang Niu; Huanran Tan
Journal:  Gene       Date:  2013-07-13       Impact factor: 3.688

8.  Resistin induces rat insulinoma cell RINm5F apoptosis.

Authors:  Chun-lin Gao; De-yu Zhao; Jie Qiu; Chun-mei Zhang; Chen-bo Ji; Xiao-hui Chen; Feng Liu; Xi-rong Guo
Journal:  Mol Biol Rep       Date:  2008-10-07       Impact factor: 2.316

Review 9.  The mechanisms linking adiposopathy to type 2 diabetes.

Authors:  Jichun Yang; Jihong Kang; Youfei Guan
Journal:  Front Med       Date:  2013-10-01       Impact factor: 4.592

10.  RESISTIN INHIBITS GLUCOSE-STIMULATED INSULIN SECRETION THROUGH MIR-494 BY TARGET ON STXBP5.

Authors:  F Wen; Y Yang; C Sun; H Fang; L Nie; L Li; Y Liu; Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.